Publicações

Functional Mapping of Akt Signaling and Biomarkers of Response from the Fairlane Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer

AuthID
P-00W-7VR

Author(s)

Shi, Z

Wulfkuhle, J

Nowicka, M

Gallagher, RI

Saura, C

Nuciforo, PG

Calvo, I

Andersen, J

Passos Coelho, JL

Gil Gil, MJ

Bermejo, B

Pratt, DA

Ciruelos, EM

Villagrasa, P

Wongchenko, MJ

Petricoin, EF

Oliveira, M

Isakoff, SJ

Tipo de Documento

Article

Year published

2022

Publicado

in CLINICAL CANCER RESEARCH, ISSN: 1078-0432

Volume: 28, Número: 5, Páginas: 993-1003 (11)

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1158/1078-0432.ccr-21-2498

Pubmed: 34907082

SCOPUS: 2-s2.0-85125729523

Wos: WOS:000767267300001

Source Identifiers

ISSN: 1078-0432

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Functional Mapping of Akt Signaling and Biomarkers of Response from the Fairlane Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Functional Mapping of Akt Signaling and Biomarkers of Response from the Fairlane Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer

Links Úteis

Ajuda